SynthesisBMC gastroenterology2025

Comparative efficacy and safety of distinct PD-1 antibodies in unresectable advanced or recurrent gastric and gastroesophageal junction cancer: a network meta-analysis of randomized controlled trials.

Mengting Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.